WINNING
CHEMISTRY Aggressive deadlines. Challenging chemistry. Complex transfers. Regulatory compliance.
technology
Why take chances w i t h the synthesis or manufacture of your preclinical candidates, clinical trial ingredients and APIs? The stakes are h i g h — a n d so is the risk w h e n w o r k i n g w i t h others.
From drug discovery to manufacturing, we can provide the competitive edge. Discovery: Lead-generation technologies, supported by world class lead optimization. Development: A full range of chemical and bioprocess research, scale-up and development expertise.
Albany Molecular Research, Inc. (AMRI) is a tested and proven partner, backed by years of successful collaborations, customer audits and FDA inspections. Over 400 scientists devoted t o solving even the most challenging problems. More than $ 125 million in recent facility and e q u i p m e n t upgrades. On-site analytical support, including m e t h o d development, structure elucidation, and physical characterization. And unmatched productivity, communication and customer satisfaction.
Analytical: Cutting-edge equipment and broad technologies,from chromatography and spectroscopy, to stability and physical chemistry studies.
There are better things t o gamble o n . Choose a partner that has experience, and the right combination of tools, technologies and k n o w - h o w for your project. Speed. Quality. Reliability. Experience. By any metric, w o r k i n g w i t h AMRI is a w i n n i n g scenario.
©
Albany Molecular Research. Inc.
Manufacturing: cGMP synthesis capabilities, from clinical trial APIs to commercial bulk actives, including controlled substances and high potency. Visit b o o t h #2323 at INFORMEX* 2 0 0 4 , or www.albmolecular.com/informex for more information. 21 Corporate Circle, P.O. Box 15098 Albany, NY 12212-5098 Phone: 518-464-0279 • Fax: 518-464-0289
[email protected]
